the timing of the sleep episode. DSPS, the more commonly reported of these disorders (Ando et al., 2001; Schrader et al., 1993) , with a particularly higher prevalence among adolescents and young adults (Pelayo et al., 1988; Regestein and Monk, 1995) , is defined by a persistent inability to fall asleep and/or awaken as early as desired. An individual with DSPS is typically unable to fall asleep before 0200 h and if allowed to sleep and wake at will, awakens between 1000 h and 1300 h . In some cases, enforced morning awakenings imposed by work and school schedules result in chronic sleep loss. This schedule of sleep restriction could have serious consequences for health and performance (Banks and Dinges, 2007; Van Cauter et al., 2007; Van Dongen et al., 2003) .
Various measures of sleep timing and circadian phase have been examined in individuals with DSPS (Ozaki et al., 1996; Rodenbeck et al., 1998; Uchiyama et al., 1999 Uchiyama et al., , 2000 Watanabe et al., 2003; Wyatt et al., 2006) . There has also been some progress made to identify the genetic basis underlying DSPS (Archer et al., 2003; Ebisawa et al., 1999 Ebisawa et al., , 2000 Ebisawa et al., , 2001 Hohjoh et al., 1999 Hohjoh et al., , 2003 Takano et al., 2004) , but there is still a great deal to learn about the cause and pathophysiology of the circadian rhythm sleep disorders. Several possible mechanisms could account for a persistently altered phase of sleep timing to the environment. These include a long endogenous circadian period, masking of the advanced region of the light phase response curve (PRC), an altered response to the phaseresetting effects of light, and an altered phase relationship between the circadian clock and the sleep-wake rhythm. A change in the phase relationship between habitual sleep timing and circadian phase may explain both the persistent delay in the sleep-wake times and difficulty initiating sleep at earlier times experienced by patients with DSPS.
The retrospective study presented here describes the phenotypic characterization of a large clinic-based DSPS population. Our goal is to examine sleep parameters, circadian phase (melatonin and core body temperature rhythms), and phase angle between circadian markers and sleep schedule in DSPS patients and to determine if they are significantly different from age-matched control subjects. We hypothesized that, similar to what has been reported in the literature, the DSPS group will exhibit delays of their habitual sleep timing and circadian phase and that the phase relationship between sleep and circadian phase of melatonin and temperature rhythms will be altered in DSPS subjects, as has been previously reported in small samples (Ozaki et al., 1996; Rodenbeck et al., 1998; Uchiyama et al., 1999 Uchiyama et al., , 2000 Watanabe et al., 2003) . Our findings expand on these prior studies to include examination of sleep timing and circadian phase in a large number of DSPS patients living under their usual entrained conditions.
MATERIALS AND METHODS

Subjects
Data were collected from a total of 122 subjects: 66 individuals diagnosed with DSPS (35 females) and 56 healthy control subjects (26 females) over a 7-year period between 1999 and 2006. The work was conducted at the Northwestern University Feinberg School of Medicine. The mean age ± standard deviation (SD) of the DSPS group was 30 ± 10 years with an age range of 16 to 62 years. Control subjects were agematched to the DSPS group; there was a mean age of 32 ± 13 years and age range of 19 to 74 years and there was no significant difference in age between the groups (p = 0.41). Clinical diagnosis of circadian rhythm sleep disorder patients was determined by physician interview and according to The International Classification of Sleep Disorders Revised: Diagnostic and Coding Manual (ICSD; and the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV; American Psychiatric Association, 2000). Collection of sleep and circadian measures in DSPS patients and analysis of these data for this retrospective study was approved by the Northwestern University Institutional Review Board. All control subjects were recruited for participation in unrelated sleep research studies and gave informed written consent prior to enrollment. Only baseline data collected from control subjects were analyzed in this study. A subset of the DSPS patients in this study gave informed written consent to participate in an unrelated study of oral melatonin administration as a therapeutic treatment (Mundey et al., 2005) , and only baseline data collected in naïve patients, prior to intervention, were included in the present analysis.
Monitoring Sleep-Wake Activity
All subjects, DSPS and control, were asked to wear wrist activity monitors and maintain daily sleep diaries for a minimum of 1 week to determine habitual bedtimes and sleep times while living in their home environment. To detect any differences in sleep schedule between weekdays and weekends, sleep measures from at least 4 weekdays and 2 weekend days were analyzed. Weekdays included bedtime Sunday through wake time Friday and weekends included bedtime Friday through wake time Sunday. Bedtimes, wake times, estimated total sleep time, sleep latency, wake after sleep onset, naps, and any unusual events during the day or night were recorded in the sleep logs. From the reported sleep times, several measures were used for analysis: bedtime, wake time, and time in bed (bedtime to wake time). The Actiwatch system (Mini-Mitter/Respironics, Bend, OR) was used to record activity. Each subject wore an actigraph continuously (except when bathing or swimming) on the wrist of the nondominant hand. Daily activity data recorded via the wrist monitors were analyzed using Actiware version 3.4 software (Mini-Mitter/ Respironics) to verify sleep periods reported in sleep logs and to objectively determine sleep onset, sleep offset, and sleep duration (sleep onset to offset) per nightly sleep episode. A combination of both sleep diary and actigraphic data were used to determine sleep latency (bedtime to sleep onset), and sleep efficiency (actual sleep/time in bed).
Measuring Melatonin and Determination of DLMO
Saliva samples were collected from a subset of DSPS participants (n = 17) in their homes to determine dim light melatonin onsets (DLMO). Participants were instructed to collect samples using Salivette tubes every 30 min under dim light conditions (at most, a side lamp or television in the room) beginning 4 h prior to habitual bedtime until sleep time. Subjects were asked to refrain from eating or drinking 20 min prior to sample collection (Mundey et al., 2005) . Salivary melatonin samples were measured using a Buhlmann Saliva direct radioimmunoassay (ALPCO, Windham, NH). The lower limit of functional sensitivity is 0.9 pg/mL; the intra-assay coefficient of variance was 4.1% at 3.56 pg/mL and the interassay coefficient of variance was 7.5% at 3.39 pg/mL (Mundey et al., 2005) .
Plasma melatonin was measured in a subset of DSPS patients (n = 8) and a majority of control participants (n = 31) from blood samples collected under dim light conditions (<20 lux) in the General Clinical Research Center (GCRC) at a 20-30-min interval. Blood sampling began approximately 24 h following admission to the GCRC during which participants were kept in modified entrainment conditions: dim light (<20 lux) during wake, darkness during sleep scheduled at habitual sleep/wake times, and restricted activity to avoid vigorous exercise. A sterile heparin-lock catheter was inserted in the forearm 2 h before the beginning of sampling, and the IV line was kept patent by a slow drip of heparinized saline. Blood samples were collected using plastic syringes connected to the lateral arm of a 3-way stopcock. During waking hours, the stopcock was attached directly to the antecubital catheter, and during sleep, the indwelling catheter was connected to plastic tubing extending to an adjacent room . Plasma melatonin samples from each individual were measured in the GCRC core laboratory using commercially available reagents (Stockgrand LTD, University of Surrey, Guilford, Surrey, UK) with a procedure developed by J. Arendt (University of Surrey) using an antimelatonin antiserum raised in a rabbit by Dr. J.P. Ravault (Nouzilly, France). This antiserum has been validated for the assay of melatonin in human plasma using an iodinated melatonin tracer. The lower limit of sensitivity was 2.5 pg/mL. The intra-assay coefficient of variation averaged 15% to 17.5% for values <10 pg/mL, and 5% to 16% for values >10 pg/mL. The interassay coefficient of variation averaged ~20 for values <10 pg/mL and ~13.5% for values >10 pg/mL (Baehr et al., 2003; Benloucif et al., 2005) .
Salivary melatonin has been validated as a circadian phase marker and the timing of different melatonin profile parameters determined from saliva samples was significantly correlated to those using plasma melatonin assay in a general subject population (Laakso et al., 1990; McIntyre et al., 1987; Voultsios et al., 1997) and specifically in DSPS patients (Nagtegaal et al., 1998) . To determine the DLMO from salivary and plasma samples, onsets were calculated as the time of the 1st sample greater than 2 standard deviations above the basal mean (Lewy et al., 1999; Voultsios et al., 1997) .
Measuring Core Body Temperature and Determination of Nadir
To determine the circadian phase of core body temperature (CBT), all participants (DSPS and control) were asked to wear a rectal thermistor for a minimum of 36 h (Mini Logger, Mini-Mitter/Respironics). This flexible rectal thermometer, connected to a lightweight data-recording unit, was used to sample CBT every minute over this period of time. DSPS patients were given a temperature-recording unit after detai led explanation of its use for home recording. Core body temperature recording in control subjects was done during their stay in the GCRC under ambulatory conditions. The 24-h CBT profiles were quantitatively described using the Cleveland regression procedure to assess the phase of the rhy thm (Cleveland, 1979) . The phase of CBT was characterized by the timing of the fitted nocturnal minimum (CBT nadir ).
Determining Phase Angle of Entrainment
Four different phase angle measures were determined using the melatonin, temperature, and actigrap hic data. The actigraphy data was usually collected for a minimum of 1 week before and during collection of melatonin and/or temperature data for phase determination in the GCRC studies and concomitantly (during the last 2 days of the actigraphy) for at-home studies. This interval between actigraphy and circadian phase measure was typically 0 to 2 days. Phase angles were cal culated as the difference between a circadian phase marker (DLMO or CBT nadir ) and a mean sleep timing measure (sleep onset or offset). These 4 measures were defined as: DLMO-sleep onset, DLMO-sleep offset, CBT nadir -sleep onset, and CBT nadir -sleep offset.
Statistical Tests
Unpaired t tests were used for comparisons of sleep, circadian phase, and phase angle measures between the groups (DSPS vs. controls, SPSS 11). Paired t tests were used for comparisons of sleep measures during weekdays and weekends for all subjects. A 2-way analysis of variance (ANOVA) was used to compare sleep measures during weekdays and weekends bet ween DSPS and control groups (Prism 4.0c). Subj ective measures of sleep schedules were correlated with objective actigraphy-derived sleep measures for all subjects. Differences with a p value less than 0.05 were considered significant.
RESULTS
Habitual Sleep Schedule
Wrist actigraphy and sleep diaries were collected in 122 subjects (66 DSPS and 56 controls). Six sleep measures were assessed for both participant groups. Actigraphic recordings correlated very highly with selfreported diaries for sleep measures: bedtime versus sleep onset (r 2 = 0.93, p < 0.001); wake time versus sleep offset (r 2 = 0.99, p < 0.001). DSPS patients had significantly later sleep-wake times when compared with controls (p < 0.001), although they did not differ in the amount of time in bed or duration of sleep (see Fig. 1 ). Furthermore, there was no difference in sleep latency or sleep efficiency between the 2 groups.
Habitual sleep measures from a minimum of 4 weekdays and 2 weekend days were collected from a total of 121 subjects (65 DSPS and 56 controls). A comparison of sleep measures for weekdays and weekends for both subject groups is shown in Figure  2 . On the weekends all subjects, DSPS and controls, regardless of diagnostic status, were going to bed later (by 29 min) and waking later (by 50 min) compared with the weekdays (p < 0.05). Additionally, all subjects spent significantly more time in bed (26 min) and slept longer (21 min) on weekends (p < 0.05). There was no difference in sleep latency or sleep efficiency between weekdays and weekends. Results from the 2-way ANOVA showed only significant differences in bedtime, wake time, sleep onset, and sleep offset between DSPS and controls (all p < 0.0001).
Circadian Phase of Melatonin and CBT Rhythms
Salivary melatonin was collected in 17 DSPS patients and plasma melatonin was collected in 8 DSPS participants and 31 controls. CBT was collected in 82 subjects (40 DSPS and 42 controls). DSPS patients were significantly phase delayed in both the melatonin and CBT rhythms, relative to the age-matched control group (see Fig. 3 , top panel). The mean DLMO was delayed by more than 2 h (p < 0.001) and the mean CBT nadir occurred about 2.5 h later (p < 0.001) in the DSPS group. The salivary melatonin phase (DLMO) of the 17 DSPS patients was compared with the DLMO determined from plasma samples of the 8 DSPS participants to test for factors of sample type and the conditions under which they were collected that could influence the results. The DLMO was not significantly different in these 2 groups (p = 0.81, t test).
Phase Angle: Relationship Between Circadian Phase Markers and Sleep Timing
Four phase angles between circadian phase markers (DLMO and CBT nadir ) and habitual sleep schedule (sleep onset and offset) were determined. Figure 3 , bottom panel, shows the comparison of DSPS subjects and age-matched controls. Although DSPS patients exhibit a significantly later phase of both melatonin and temperature rhythms as well as later sleep and wake times when compared with controls, the circadian phase angle was not significantly different between the DSPS and control groups for any of the intervals measured (p = 0.63, 1.00, 0.10, and 0.89, respectively).
DISCUSSION
The current study expands upon prior studies of DSPS in 2 important ways: the large sample size in which subjective and objective sleep measures and circadian phase markers were collected, and the use of portable data collection of these measures from DSPS patients in their natural home environments. This DSPS population, as a group, demonstrated a consistent delay in the timing of the sleep episode compared with controls, but based on sleep diaries and wrist actigraphy did not appear to have difficulty falling asleep. Furthermore, they showed no differences in amount of time in bed, sleep duration, or sleep efficiency. These results are surprising given that 1 of the major complaints of DSPS subjects is sleep onset insomnia or an inability to fall asleep at the desired time, which may manifest as long sleep latencies. Although there were some DSPS individuals exhibiting particularly long sleep latencies (>1 hour in 8 DSPS and 6 control subjects), the group on average took only 6 min longer to fall asleep than controls, a difference that is not significant. This suggests that these DSPS patients were maintaining a habitual sleep schedule that was later than they desired and significantly later than the control group. These patients came to the sleep center to seek treatment to advance the timing of their sleep and wake cycle. Maintaining a dela yed bedtime did not appear to show, in our study, adverse consequences of longer sleep latency or decr eased sleep efficiency. A comparison of sleep schedules on weekdays and weekends showed that all participants were going to bed and waking at significantly later times on the weekend. Both DSPS and control groups spent significantly more time in bed and slept longer on weekends, presumably due to a less restricted schedule free from work/school obligations. This indicates that both groups were restricting sleep during weekdays and making up a "sleep deficit" during weekends. It is interesting to note that even though both groups slept significantly more on the weekends, there was no difference between DSPS and control groups in sleep duration for either weekends or weekdays. This result is in contrast to other published reports of DSPS patients having longer sleep durations than control subjects (Ozaki et al., 1996; Shibui et al., 1999; Uchiyama et al., 2000; Watanabe et al., 2003) . Taken together, these results show that the DSPS population studied here had a persistent delay in sleep timing with no evidence for longer sleep duration, difficulty falling asleep, or staying asleep. Our findings suggest that under entrained conditions, when allowed to sleep at their habitual sleep times, DSPS patients had normal sleep.
There were significant differences in the circadian phase markers of both temperature and melatonin rhythms, with DSPS patients having a characteristically later CBT nadir and DLMO relative to controls. Examination of the phase relationship between sleep measures and the phase of the body temperature rhythm did not show an alteration between either sleep onset or offset and CBT nadir in DSPS patients compared with controls. These results differ from reports of a longer phase interval between CBT nadir and sleep offset in DSPS patients (Ozaki et al., 1996; Uchiyama et al., 2000; Watanabe et al., 2003) . In these previous studies, there was no difference in the phase relationship between CBT nadir and sleep onset, only with sleep offset, which is most likely due to significantly longer sleep durations and therefore later sleep offset times reported in their DSPS patients compared with our population. We found no significant difference in the phase relationship between sleep time and DLMO in DSPS patients compared with controls, as had been previously reported . Again, this may be due to longer sleep durations and subsequent longer interval between wake time and melatonin phase measures in the previously published DSPS group that we did not find in our study. Our findings are consistent with a more recent report (Wyatt et al., 2006) in which there was no difference in phase angle of DLMO and sleep between DSPS and control groups. Furthermore, it is possible that genetic differences in circadian and homeostatic regulation of sleep and wake may have accounted for the observed difference between the Japanese and US studies, particularly as there have been reported differences in the prevalence of polymorphisms in clock genes reported in different ethnic populations (Ciarleglio et al., 2008; Hawkins et al., 2008; Mishima et al., 2005) .
The significant delay in both phase markers without an accompanying alteration in the phase angle of entrainment suggests that although DSPS subjects exhibit later sleep-wake times under entrained conditions, they are not sleeping at an "adverse" circadian phase for maximum sleep efficiency. This is consistent with our sleep timing results demonstrating that the DSPS group did not show greater sleep latencies than controls. Taken together, our findings suggest that when allowed to sleep at their own habitual schedules, patients with DSPS have both normal sleep parameters and circadian phase angle.
There have been a number of possible explanations proposed for the delayed timing of the sleep episode in DSPS patients, including a longer endogenous circadian period, which would require a greater daily phase advance to entrain to the 24-h day. If DSPS individuals are not receiving light, the strongest entraining stimulus, at the early part of day where it will cause a phase advance, they may exhibit a delayed sleep schedule. Independent of circadian period length, the sleep-wake schedule for individuals with DSPS, on average, is considerably later than controls and suggests they may not be receiving light in the early portion of the day when they may be still asleep. Furthermore, inasmuch as they are awake later in the evening/night, they may be receiving light in the delay region of the photic PRC, which would delay their sleep even more. The current study was conducted with individuals living in their home environments, presumably under 24-h entrained conditions, and therefore endogenous circadian per iod was not assessed.
Alternatively, it has been proposed that DSPS individuals may have an altered response to light: altered sensitivity to light, smaller phase advance region, or larger phase delay region of the light PRC . Another possible explanation is that DSPS subjects have an altered phase relationship between their circadian phase and the light/dark cycle. In laboratory studies of young morning-and evening-type individuals, where the light/dark cycle and sleep-wake timing was controlled, there was a phase angle difference showing that morning types were waking at an earlier circadian phase than evening types (Duffy et al., 1999) . Although our results do not show an altered phase angle between sleep schedule and circadian phase, we do not know the light/dark conditions, which may differ somewhat from the sleep-wake times for these subjects.
These findings have implications for both diagnosis and treatment of this disorder. At the time of diagnosis of most of the DSPS subjects in this retrospective study, the clinical diagnostic criteria did not require physiologic measures of circadian phase. Since then, there have been revisions made to both the ICSD and DSM-IV criteria that include these measures. Additionally, actigraphy and/or polysomnography have been added to the criteria to confirm the delay of the sleep schedule. Ultimately, the single criterion that remains critical to a clinical diagnosis of DSPS is a self-reported sleep-related complaint by the individual. Results from actigraphic recordings, sleep diaries, and physiologic phase measures, although confirming the delayed timing of the sleep episode and circadian phase, do not support the maladaptive response to this pattern that forms the basis of the sleep complaint. We found no difference in sleep latency, sleep duration, or sleep efficiency between DSPS subjects and controls that would indicate difficulty initiating or maintaining sleep. The analysis of sleep on weekdays and weekends further showed that both groups were extending sleep when given the opportunity, but the DSPS group did not show a longer sleep episode that might indicate greater sleep pressure, relative to the control group. Because we found no significant difference in the phase relationship of sleep timing and circadian phase between the 2 groups, the DSPS group does not appear to be sleeping at an "adverse" circadian phase that could exp lain sleep problems. Again, the greater variability seen in the DSPS group suggests that although our measures from the large group, on average, do not differ from the controls, there are likely greater interindividual differences and multiple symptoms leading to the sleep complaint, suggesting various mechanisms that could explain the consistent delayed sleep phase that is common to these individuals. To this end, objective measures obtained in the subjects' home environment may be very useful in characterizing a more precise schedule of sleep and timing of circadian phase that may explain the sleep complaint and also help determine the proper manner and timing of treatment.
